DETECTING AND CLASSIFYING COPY NUMBER VARIATION

Patent №

US 9,260,745

Granted

2016-02-16

Filed 2012

Owner

VERINATA HEALTH, INC.

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

13555037

The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to differ in the amount of one or more sequence of interest. The method comprises a statistical approach that accounts for accrued variability stemming from process-related, interchromosomal and inter-sequencing variability. The method is applicable to determining CNV of any fetal aneuploidy, and CNVs known or suspected to be associated with a variety of medical conditions. CNV that can be determined according to the method include trisomies and monosomies of any one or more of chromosomes 1-22, X and Y, other chromosomal polysomies, and deletions and/or duplications of segments of any one or more of the chromosomes, which can be detected by sequencing only once the nucleic acids of a test sample.

PlanningC12Q 1/6874C12Q 1/6806C12Q 1/6809C12Q 1/6869G16B 30/00G16B 30/10C12Q 1/6883C12Q 1/6886+1 more

AI classification

Planning0.81
AI hardware0.06
Vision0.02
Natural language0.02
Evolutionary computation0.00
Machine learning0.00
Knowledge representation0.00
Speech0.00

Ownership

VERINATA HEALTH, INC.

assignment · 291540537

Assignors

RAVA, RICHARD P., RHEES, BRIAN K.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC